Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma

Cancer Research

Volumn 57, Issue 24, 1997, Pages 5571-5578

  Hughes, Steven J ^a   Nambu, Yoshihiro ^b   Soldes, Oliver S ^a   Hamstra, Daniel ^a   Rehemtulla, Alnawaz ^a   Iannettoni, Mark D ^a   Orringer, Mark B ^a   Beer, David G ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER CELL CULTURE; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN TRANSPORT; SEQUENCE ANALYSIS;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BARRETT ESOPHAGUS; BLOTTING, SOUTHERN; CELL MEMBRANE; COS CELLS; DNA; DNA, NEOPLASM; EPITHELIUM; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; RISK FACTORS; TUMOR CELLS, CULTURED;

EID: 0031454760     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Steller, H., Mechanisms and genes of cellular suicide. Science (Washington DC), 267: 1445-1449, 1995.
2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1461, 1995.
3. Trauth, C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K-M., and Krammer, P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Washington DC), 245: 301-305, 1989.
4. Yonehara, S., Ishii, A., and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169: 1747-1756, 1989.
5. Nagata, S., and Goldstein, P. The Fas death factor. Science (Washington, DC), 267: 1449-1456, 1995.
6. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S-I., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediated apoptosis. Cell, 66: 233-243, 1991.
7. Rudert, F., Visser, E., Forbes, L., Lindridege, E., Wang, Y., and Watson, J. Indentification of a silencer, enhancer, and basal promotor region in the human CD95 (Fas/APO-1) gene. DNA Cell Biol., 14: 931-937, 1995.
8. Owen-Schaub, L. B., Radinsky, R., Kruzel, E., Berry, K., and Yonehara, S. Anti-Fas on nonhematopoetic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res., 54: 1580-1586, 1994.
9. Rokhlin, O. W., Bishop, G. A., Hostager, B. S., Waldschmidt, T. J., Sidorenko, S. P., Pavloff, N., Kiefer, M. C. Umansky, S. R., Glover, R. A., and Cohen, M. B. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res., 57: 1758-1768, 1997.
10. Fuse, Y., Nishimura, H., Maeda, K., and Yoshikai, Y. CD95 (Fas) may control the expansion of activated T cells after elimination of bacteria in murine listeriosis. Infect. Immun., 65: 1883-1891, 1997.
11. Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K-M., Krammer, P. H., and Möller, P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69: 415-429, 1993.
12. Möller, P., Koretz, K., Leithäuser, F., Brüderlein, S., Henne, C., Quentmeier, A., and Krammer, P. H. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer, 57: 371-377, 1994.
13. Keane, M. M., Ettenberg, S. A., Lowrey, G. A., Russell, E. K., and Lipkowitz, S. Fas expression and function in normal and malignant breast cell lines. Cancer Res., 56: 4791-4798, 1996.
14. Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y., and Fontana, A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. Clin. Invest., 94: 954-964, 1994.
15. Takeuchi, T., Sasaki, Y., Ueki, T., Kaziwara, T., Moriyama, N., Kawabe, K., and Kakizoe, T. Modulation of growth and apoptosis response in PC-3 and LNCaP prostate-cancer cell lines by Fas. Int. J. Cancer, 67: 709-714, 1996.
16. Landowski, T. H., Gleason-Guzman, M. C., and Dalton, W. S. Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood, 89: 1854-1861, 1997.
17. Roth, W., Fontana, A., Trepel, M., Rees, J. C., Dichgans, J., and Weller, M. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics. Cancer Immunol. Immunother., 44: 55-63, 1997.
18. Winters, D., Spurling, T. J., Chobainian, S. J., Curtis, D. J., Esposito, R. L., Hacker, J. F., Johnson, D. A., Cruess, D. F., Cotelingham, J. D., Gurney, M. S., and Cattau, E. L. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology, 92: 188-124, 1987.
19. Spechler, S. J., and Goyal, R. K. Barrett's esophagus. N. Engl. J. Med., 315: 362-371, 1986.
20. Blot, W. J., Devesa, S. S., Kneller, R. W., and Fraumeni, J. F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J. Am. Med. Assoc., 265: 1287-1289, 1991.
21. Gleeson, C. M., Sloan, J. M., McGuigan, J. A., Ritchie, A. J., and Russell, S. E. H. Base transition at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res., 55: 3406-3411, 1995.
22. Goldblum, J. R., and Rice, T. W. bcl-2 protein expression in the Barrett's metaplasiadysplasia-carcinoma sequence. Mod. Pathol., 8: 866-869, 1995.
23. Stoner, G. D., Kaighn, M. E., Ressel, R. R., Resau, J. H., Bowman, D., Naito, Z., Matsukura, N., You, M., Galati, A. J., and Harris, C. C. Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res., 57: 365-371, 1991.
24. Jaattella, M., Benedict, M., Tewari, M., Shayman, J. A., and Dixit, V. M. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene, 10: 2297-2305, 1995.
25. Cheng, J., Zhou, T., Liu, C, Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., and Mountz, J. D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science (Washington DC), 263: 1759-1762, 1994.
26. Watson, A. J. M. Manipulation of cell death-the development of novel strategies for the treatment of gastrointestinal disease. Aliment. Pharmacol. Ther., 9: 215-226, 1995.
27. Al-Kasspooles, M., Moore, J. H., Orringer, M. B., and Beer, D. G. Amplification and overexpression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int. J. Cancer, 54: 213-219, 1993.
28. Nicoletti, I., Mgliorati, G., Pagliacci, M. C., Grignani, F., and Riccadi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
29. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
30. Cascino, I., Fiucci, G., Popoff, P., and Ruberti, G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol., 154: 2706-2713, 1995.
31. Davies, M. V., and Kaufman, R. J. Internal translation initiation in the design of improved expression vectors. Curr. Opin. Biotechnol., 3: 512-517, 1992.
32. Kaufman, R. J. Vectors used for expression in mammalian cells. In: D. Goeddel (ed.), Methods in Enzymology, Vol. 185, p. 487. San Diego: Academic Press, 1990.
33. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, M. D. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81: 505-512, 1995.
34. Cai, Z., Stancou, R., Körner, M., and Chouaib, S. Impairment of Fas-antigen expression in Adriamycin-resistant but not TNF-resistant MCF7 tumor cells. Int. J. Cancer, 68: 535-546, 1996.
35. Weller, M., Malipiero, U., Rensing-Ehl, A., Barr, P. J., and Fontana, A. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res., 55: 2936-2944, 1995.
36. Mizutani, Y., Okada, Y., Yoshida, O., Fukumoto, M., and Bonavida, B. Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity. Cancer (Phila.), 79: 1180-1190, 1997.